Prolife IndustriesNSE:PROLIFE +4.99%61 EBITDA Margin % is 7.66% as of Mar. 2025, which is 45% below its 10-year median of 13.89. GuruFocus rates NSE:PROLIFE with a GF Score™ of 61/100 and a GF Value™ of ₹167.09 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,585 Chemicals companies, Prolife Industries ranks better than 66.12% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Prolife Industries's EBITDA for the
six
months ended in Mar. 2025 was ₹22.1 Mil. Prolife Industries's Revenue for the
six
months ended in Mar. 2025 was ₹287.9 Mil. Therefore, Prolife Industries's EBITDA margin for the quarter that ended in Mar. 2025 was 7.66%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Prolife Industries EBITDA Margin % Related Terms
Prolife Industries EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Prolife Industries's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Prolife Industries's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prolife Industries EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Prolife Industries's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Prolife Industries's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prolife Industries (NSE:PROLIFE) has a EBITDA Margin % of 7.66% as of Mar. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Prolife Industries and its competitors. This is 45% below median its historical median of 13.89. Over the past decade, Prolife Industries' EBITDA Margin % has ranged from 9.64 to 23.59. According to the industry distribution chart, Prolife Industries ranks #537 out of 1585 companies in the Chemicals industry, placing it in the top 33.9%.
Is Prolife Industries' EBITDA Margin % too high?
Prolife Industries' current EBITDA Margin % of 7.66% is 45% below median its 10-year median of 13.89. Over the past 10 years, this metric has ranged from a low of 9.64 to a high of 23.59. The Chemicals industry median EBITDA Margin % is 9.63. Prolife Industries' value of 7.66% is 20.5% below this industry median. Based on the distribution chart, Prolife Industries ranks #537 out of 1585 companies in the Chemicals industry, which is above the industry midpoint. Overall, Prolife Industries has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prolife Industries' EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Prolife Industries ranks #537 out of 1585 companies for EBITDA Margin %. This puts Prolife Industries in the upper half of its industry. The industry median EBITDA Margin % is 9.63. Prolife Industries' value of 7.66% is 20.5% below this benchmark. Historically, Prolife Industries' own EBITDA Margin % has ranged from 9.64 to 23.59 over the past decade. While the company's 10-year median is 13.89 vs. the industry median of 9.63, Prolife Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prolife Industries's current EBITDA Margin % of 7.66% is 20.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Prolife Industries and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prolife Industries's current EBITDA Margin % is 7.66%, which is 45% below median its own 10-year median of 13.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prolife Industries stock overvalued right now?
Based on GuruFocus' analysis, Prolife Industries (NSE:PROLIFE) is currently considered Possible Value Trap. The stock's GF Value™ is ₹167.09, compared to a current price of ₹75.80 — trading 54.6% below its estimated fair value. The current EBITDA Margin % is 7.66%, which is 45% below median its 10-year median of 13.89 and 20.5% below the Chemicals industry median of 9.63. Prolife Industries' overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Prolife Industries (NSE:PROLIFE), the current EBITDA Margin % is 7.66% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prolife Industries (NSE:PROLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, Prolife Industries stock appears to be undervalued.
The current stock price of ₹75.80 is trading 54.6% below its estimated GF Value™ of ₹167.09.
GuruFocus considers Prolife Industries to be Possible Value Trap.
Key valuation signals for NSE:PROLIFE:
EBITDA Margin %: 7.66% (45% below median its 10-year median of 13.89)
GF Value™: ₹167.09 vs. price of ₹75.80 (54.6% below fair value)
Industry Position: 20.5% below the Chemicals median (#537 of 1585)
No single metric tells the full story. See the NSE:PROLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prolife Industries Ltd is engaged in the business of manufacturing of intermediates for dyes, pigments, pharmaceuticals, agrochemicals, and others. Its products include Dihydro Thio Para Toluidine Sulfonic Acid, Amino Methyl Phenoxy Sulfonic Acid, and others. The company derives revenue from both domestic and overseas markets, which are considered different geographical segments.
61GF Score
Get the complete analysis for NSE:PROLIFE
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PROLIFE has been successfully added to your 
